Related Experiment Video

Updated: May 15, 2026

Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
10:02

Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)

Published on: March 12, 2020

Pharmacologic intervention for attention-deficit hyperactivity disorder in preschoolers : is it justified?

Jaswinder K Ghuman1, Harinder S Ghuman

  • 1Child and Adolescent Psychiatry, University of Arizona, Tucson, AZ 85724-5002, USA. jkghuman@email.arizona.edu

Paediatric Drugs
|January 19, 2013
PubMed

Insights

Pharmacologic treatment for attention-deficit hyperactivity disorder (ADHD) in preschoolers shows small benefits but carries risks. Careful monitoring and trials off medication are recommended if behavior therapy fails.

Area of Science:

  • Pediatric Psychiatry
  • Neurodevelopmental Disorders
  • Child Psychology

Background:

  • Attention-deficit hyperactivity disorder (ADHD) in preschoolers is a complex condition.
  • Non-pharmacologic interventions are effective but not universally accessible or preferred.
  • Pharmacologic intervention for preschool ADHD remains controversial due to safety and efficacy concerns.

Purpose of the Study:

  • To review the current evidence on pharmacologic interventions for ADHD in preschoolers.
  • To outline guidelines for initiating and monitoring psychopharmacologic treatment in this age group.
  • To highlight the need for further research on long-term outcomes and personalized treatment.

Main Methods:

  • Review of existing literature and guidelines on ADHD treatment in preschoolers.
  • Analysis of findings from the Preschool ADHD Treatment Study regarding methylphenidate.
  • Discussion of adverse effects and safety considerations.

Main Results:

  • Immediate-release methylphenidate showed small to moderate benefits in preschoolers with ADHD.
  • Preschoolers experienced a high rate of adverse effects with methylphenidate.
  • Limited data exists on the long-term safety and neurodevelopmental effects of ADHD medications in young children.

Conclusions:

  • Pharmacologic treatment for preschool ADHD is indicated only after behavioral therapy fails and symptoms significantly impair functioning.
  • Close monitoring for adverse effects is crucial, with medication trials off medication recommended after six months.
  • Further research is essential to identify predictors of treatment response and optimize individualized care for preschoolers with ADHD.

More Related Videos

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients05:48

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

Published on: June 12, 2020

Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol13:09

Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol

Published on: April 1, 2018

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Operant Conditioning Intervention01:24

Operant Conditioning Intervention

Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
Behavior Modification01:21

Behavior Modification

Behavioral approaches have often been criticized for ignoring mental processes and focusing solely on observable behavior. However, these approaches provide an optimistic perspective for individuals seeking to change their behaviors. Rather than concentrating on intrinsic personality traits, behavioral approaches suggest that even longstanding habits can be modified by changing the reward contingencies that maintain them.
A real-world application of operant conditioning principles is applied...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...